Plasma Cell Leukemia — Trials

Plasma Cell Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

53 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 23
Recruiting: 16
Ph III recruiting: 1
Growth YoY: —
Industry share: 9%
Top sponsor: Institute of Hematology & Blood Diseases Hospital, China
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07185490	IASO104 for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma(IASO104)	not yet recruiting	Early Phase 1	40	Institute of Hematology & Blood Diseases Hospital, ChinaOTHER	0	Jan 20, 2026	clinicaltrials
NCT06830733	Study to Evaluate the Safety and Efficacy of ARI0002h, for the Initial Treatment of Patients With Primary Plasma Cell Leukaemia(GEM-PLASMACAR)	not yet recruiting	Phase 2	25	Fundacion Clinic per a la Recerca Biomédica